Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab vs Methotrexate in Severe Psoriasis
NCT05889338Unknown
- Sponsor
- Sohag University
- Start
- Jun 2023
- Primary completion
- Jan 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Trial of adalimumab in psoriasis (2 arms), sponsored by Sohag University. Primary endpoint: Psoriasis Area and Severity Index at 6 months. Status: unknown.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT05889338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05889338.